RecruitingNCT05867004

Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma

Studying Germ cell tumor

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Institut Claudius Regaud
Principal Investigator
Bruno SEGUI, Pr
Cancer Research Center of Toulouse
Enrollment
100 target
Eligibility
18 years · All sexes
Timeline
2023 – 2026

Study locations (1)

Collaborators

Institut National de la Santé Et de la Recherche Médicale, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05867004 on ClinicalTrials.gov

Other trials for Germ cell tumor

Additional recruiting or active studies for the same condition.

See all trials for Germ cell tumor →

← Back to all trials